Top 5 Takeaways Increased Vaccine Coverage: From 2005 to 2021, coverage with the first dose of a measles-containing vaccine (MCV) increased from 68% to 89%, and the second dose from
Category: MMWR Booster
Top 5 Takeaways: Demographics and Risk Behaviors: Among 719 mpox patients in NYC, 97.9% were men, predominantly identifying as gay or queer (78.7%), or bisexual (5.6%). A significant proportion reported
Top 5 Takeaways: Bivalent mRNA Vaccine Effectiveness: The study found that bivalent mRNA vaccines are effective in preventing COVID-19–associated emergency department/urgent care encounters and hospitalizations among immunocompetent adults. Comparative Analysis:
Top 5 Takeaways: One-Dose JYNNEOS Vaccine Efficacy: One dose of JYNNEOS vaccine, administered ≥14 days before illness onset, demonstrated some protective effects against mpox, including reduced symptoms and lower hospitalization
Top 5 Takeaways 1. Effectiveness of Bivalent Booster: The study found an 84% effectiveness of the bivalent booster against COVID-19 hospitalization compared to unvaccinated individuals. 2. Relative Vaccine Effectiveness: Compared
In this entry of MMWR Booster, a summary is provided about findings regarding Clinical and Epidemiological Data in regards to Mpox in Gender Diverse Persons.
In this entry of MMWR Booster, a summary is provided about findings regarding COVID mRNA Vaccine effectiveness in preventing severe hopsitalizations and outcomes.